10^thSoCalBio
Investor Conference

September 19, 2008
Wilshire Grand Hotel

Click Here to Register Online
https://www.123signup.com/register?id=tfdhj

This conference showcases emerging biotech and device companies from Southern California seeking funding and partnerships

Download Brochure

Agenda

September 18, 6:00 to 9:00 pm
CEO/Investor Reception and Dinner (By-Invitation-Only )
September 19, 7:00 am - 7:00 pm
7:00	Registration Opens
7:45	Breakfast & Opening Remarks by Conference Co-Chair Allan Wolfe, MD, General Partner, UV Partners
8:00	Keynote Presentation: "Charting a Path Through Challenging Times" by Alan Frazier, Founder and Managing Director, Frazier Healthcare Ventures, one of the nation's leading providers of venture and growth equity capital to emerging healthcare companies with more than $1.8 billion of capital under management.
9:05	Company Presentations: Biopharmaceuticals Spectrum Pharmaceuticals (Irvine, CA): Acquisition, development and commercialization of a diverse portfolio of oncology drug candidates. TerraPharm: Focused on prescription botanical drugs and medical foods to treat major chronic diseases. Nidus Laboratories (Los Angeles, CA): Small cyclic peptides to treat immune disorders, inflammation and cancer. Adventrx (San Diego, CA): Biopharmaceutical R&D focused on proprietary therapeutic candidates for treating cancer and infectious diseases.
9:55	Coffee Break
10:10	Company Presentations: Molecular Diagnostics/Biosensors DermTech (San Diego, CA): Development and validation of molecular tests using specimens derived from skin. Tissue Genetics Inc. (Boulder, CO): Molecular diagnostics for breast and ovarian cancers. DxTerity Diagnostics (Rancho Dominguez, CA): DNA testing platforms that allow physicians to routinely and inexpensively test a patient’s genetic make-up without requiring cumbersome and expensive enzymatic testing protocols. Inscent (Irvine, CA): R&D for using insect sensory machinery to construct biosensor devices for various applications.
11:00	Coffee Break
11:15	Breakout Sessions:
	Session I (Sponsored by Ernst & Young): Strategies for Accelerating Product Development Moderator – Don Ferrera Session Keynote speaker - Amit Munshi – Co-founder, Kythera (formerly with Amgen) Panelists - Kim Blickenstaff, President and CEO, Tandem Diabetes Care, Inc. Shelly Chu – Frazier Healthcare Ventures Steve Watkins – Arcturus Capital Daniel C. Wood, Partner, Mesa Verde Venture Partners
	Session II (Sponsored by Reed Smith & Prism VentureWorks): Deals Shaping the Device and Biotech Landscape Moderators – Anthony Natale, MD, Prism VentureWorks and Ramsey Hanna, Attorney, Reed Smith Panelists - Frank Stonebanks - head of IBM’s Life Science Venture Unit Caley Castelein - Kearny Ventures Stephen Snowdy - MB Ventures Doug Fisher - New Leaf Ventures
	Session III (Sponsored by Perkins Coie): Effective Use of IP Rights When Shopping For Venture Funding Moderators – Michael Wise, Partner, Perkins Coie Panelists - John Onopchenko, Managing Director, Synergy Life Science Partners Shane Popp, Associate Director, Legal, Agensys Paul Truex, CEO & President, Anthera Pharmaceticals
12:30	Networking Luncheon
1:00	Presentation "On NIH SBIR Bridge Funding" By Michael Weingarten, Director, National Cancer Institute's SBIR and STTR program
1:15	Keynote Presentation "Opportunities for Second Generation, Broad-Market Prescription Products in an Evolving Pharmaceutical Marketplace" by Mark Goldsmith, MD, PhD (photo right), Chairman and CEO of Cogentus, a specialty pharmaceutical company developing innovative, fixed-dose combination prescription medicines serving unmet medical needs that drive significant commercial opportunities.
2:15	Company Presentations: Regenerative Medicine California Stem Cell (Irvine, CA): Focused on manufacturing high-purity human cells for therapeutic development and clinical applications. Histogen (San Diego, CA): Focused on regenerative medicine based on products manufactured by newborn human fibroblasts. Capricor: (Los Angeles, CA): Biotherapeutics for the treatment of heart disease. Organovo: Platform technology for "organ printing" that allows precise placement of cell types into structures (e.g., blood vessels and complex organs) to aid transplantation.
3:00	Company Presentations: Neuroscience Wavestate (Marina del Rey, CA): Medical device technology to improve neuro-intensive care. Anergix(Los Angeles, CA): Cell therapy for neurodegenerative disorders. EOS Neuroscience (Los Angeles, CA): Optical prostheses for the treatment of neurological diseases.
3:45	Coffee Break
4:00	Company Presentations: Orthopedics Active Life Technologies (Santa Barbara, CA): Devices for measuring the mechanical properties of bones and other hard tissues in vivo. Bone-Rad (Irvine, CA): Radioactive bone cement for use as a cost-effective treatment paradigm for managing cancer tumors in bone.
4:25	Company Presentations: Imaging & Screening Tools Integrated Endoscopy (Rancho Santa Margarita, CA): New endoscope design Radlink (Torrance, CA): An innovative manufacturer of digital medical imaging for diagnostic use. NeoMatrix (Irvine, CA): Devices that promote optimal breast health.
5:00	Company Presentations: Cardiovascular Devices Allvivo Vascular (Lake Forest, CA): Focused on developing a biomimetic coronary stent coating called ProteoGuard™ that prevents restenosis without the need for extended courses of dual antiplatelet therapy. MiCardia (Irvine, CA): Minimally invasive methods to treat heart valve disease.
5:30	Concluding Remarks
5:45	Cocktail Reception
7:00	Conference Adjourns